About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Volitionrx Ltd (NY: VNRX )

0.7750 +0.0270 (+3.61%)
Streaming Delayed Price Updated: 1:54 PM EST, Nov 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Volitionrx Ltd

< Previous 1 2 3 Next >
Sidoti's August Micro-Cap Virtual Conference
Via ACCESSWIRE
Around $1.1 Million Bet On Ring Energy? Check Out These 3 Penny Stocks Insiders Are Buying
U.S. crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
Xenetic Biosciences, Inc. and VolitionRx Limited Collaborate to Develop NETs-Targeted Adoptive Cell Therapies for the Treatment of Cancer
Via ACCESSWIRE
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter. 
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
Earnings Scheduled For May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
Via Benzinga
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings... 
Via Benzinga
Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders. 
Via Benzinga
Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket
Gainers Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading. 
Via Benzinga
Looking Into VolitionRX's Return On Capital Employed
According to data from Benzinga Pro, during Q1, VolitionRX's (AMEX:VNRX) reported sales totaled $114.21 thousand. Despite a 4.81% increase in earnings, the company posted a loss of $7.72 million. 
Via Benzinga
Recap: VolitionRX Q1 Earnings
VolitionRX (AMEX:VNRX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings VolitionRX missed estimated earnings... 
Via Benzinga
A Preview Of VolitionRX's Earnings
VolitionRX (AMEX:VNRX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that VolitionRX will... 
Via Benzinga
VolitionRX Earnings Perspective: Return On Capital Employed
Benzinga Pro data, VolitionRX (AMEX:VNRX) reported Q4 sales of $14.24 thousand. Earnings fell to a loss of $8.11 million, resulting in a 12.9% decrease from last quarter. 
Via Benzinga
Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday
Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
Sidoti December Micro Cap Virtual Conference
Presentation Times Released for 75+ Presenting Companies Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation... 
From Sidoti & Company, LLC
Via AccessWire
VolitionRx Ltd. (NYSE American: VNRX) Featured in Coverage of Benzinga’s Healthcare Small Cap Conference
Via Investor Brand Network
Sidoti Microcap Virtual Conference
A Conference Open to All Classes of Investors 70+ Companies Presenting and Meeting Interested Investors 1x1 Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / November 5, 2021 /... 
From Sidoti & Company, LLC
Via AccessWire
VolitionRX Earnings Perspective: Return On Capital Employed
According to Benzinga Pro data, during Q2, VolitionRX (AMEX:VNRX) posted sales of $24.78 thousand. Earnings were up 3.03%, but VolitionRX still reported an overall loss of $5.90... 
Via Benzinga
Sidoti Microcap Virtual Conference
Presentation Times Released for 50 Presenting Companies Wednesday and Thursday, August 18-19, 2021 NEW YORK, NY / ACCESSWIRE / August 18, 2021 / Sidoti & Company, LLC has released the presentation... 
From Sidoti & Company, LLC
Via AccessWire
VolitionRX Ltd (VNRX) Q2 2021 Earnings Call Transcript
VNRX earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Looking Into VolitionRX's Return On Capital Employed
In Q1, VolitionRX (AMEX:VNRX) posted sales of $25.53 thousand. Earnings were up 7.53%, but VolitionRX still reported an overall loss of $6.09 million. In Q4, VolitionRX brought in... 
Via Benzinga
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be... 
From Stock News Now
Via AccessWire
Topics Cannabis
Exposures Cannabis
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
Exposures Product Safety
Earnings Scheduled For August 11, 2021
Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is... 
Via Benzinga
Looking Into VolitionRX's Return On Capital Employed
During Q1, VolitionRX's (AMEX:VNRX) reported sales totaled $25.53 thousand. Despite a 7.53% in earnings, the company posted a loss of $6.09 million. VolitionRX collected $7.12... 
Via Benzinga
Volition Rx Limited (VNRX) Q1 2021 Earnings Call Transcript
VNRX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Sidoti Summer Virtual Small-Cap Conference
Presentation Times and Weblinks Released for Approximately 70 Presenting Companies Wednesday and Thursday, June 23-24, 2021 NEW YORK, NY / ACCESSWIRE / June 22, 2021 / Sidoti & Company, LLC has... 
From Sidoti & Company, LLC
Via AccessWire
Sidoti Microcap Virtual Conference
May 19 - 20, 2021 Presentation times and weblinks released for over 60 presenting companies NEW YORK, NY / ACCESSWIRE / May 18, 2021 / Sidoti & Company, LLC has released the presentation schedule and... 
From Sidoti & Company, LLC
Via AccessWire
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.